Mimedx (MDXG) FCF Margin (2011 - 2026)
Mimedx recorded quarterly FCF Margin of 2.22% in Q1 2026, down 89.38% quarter-over-quarter from 20.89% in Q4 2025, and down 336.0% year-over-year from 0.94% in Q1 2025.
Mimedx's FCF Margin history runs 16 years deep, the most recent figure standing at 2.22% for Q1 2026.
- In Q1 2026, FCF Margin fell 336.0% year-over-year to 2.22%; the TTM figure through Mar 2026 stood at 17.81% (down 79.0% YoY), while the FY2025 annual figure was 17.43%, down 133.0% from the prior year.
- FCF Margin came in at 2.22% for Q1 2026 at Mimedx, down from 20.89% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 25.96% in Q2 2024 to a low of 17.56% in Q1 2022.
- A 5-year average of 9.15% and a median of 9.2% in 2023 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin jumped 2741 bps in 2022 and tumbled 1152 bps in 2025, its largest moves.
- Mimedx's FCF Margin stood at 4.88% in 2022, then soared by 95 bps to 9.52% in 2023, then jumped by 120 bps to 20.93% in 2024, then dropped by 0 bps to 20.89% in 2025, then slumped by 89 bps to 2.22% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 2.22%, 20.89%, and 25.62% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.17% |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | 2.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.22% |
| Dec 31, 2025 | 20.89% |
| Sep 30, 2025 | 25.62% |
| Jun 30, 2025 | 14.44% |
| Mar 31, 2025 | 5.58% |
| Dec 31, 2024 | 20.93% |
| Sep 30, 2024 | 22.04% |
| Jun 30, 2024 | 25.96% |
| Mar 31, 2024 | 5.71% |
| Dec 31, 2023 | 9.52% |
| Sep 30, 2023 | 16.79% |
| Jun 30, 2023 | 9.20% |
| Mar 31, 2023 | -6.53% |
| Dec 31, 2022 | 4.88% |
| Sep 30, 2022 | 0.90% |
| Jun 30, 2022 | -5.06% |
| Mar 31, 2022 | -17.56% |
| Dec 31, 2021 | -22.53% |
| Sep 30, 2021 | 9.17% |
| Jun 30, 2021 | 1.75% |
| Mar 31, 2021 | -14.37% |
| Dec 31, 2020 | -18.12% |
| Sep 30, 2020 | -8.20% |
| Jun 30, 2020 | -6.54% |
| Mar 31, 2020 | -21.53% |
| Dec 31, 2019 | -31.18% |
| Sep 30, 2019 | -3.73% |
| Jun 30, 2019 | 2.79% |
| Mar 31, 2019 | -23.90% |
| Dec 31, 2018 | -0.32% |
| Sep 30, 2018 | 1.55% |
| Jun 30, 2018 | 19.09% |
| Mar 31, 2018 | 8.45% |
| Dec 31, 2017 | 22.46% |
| Sep 30, 2017 | 16.63% |
| Jun 30, 2017 | 16.75% |
| Mar 31, 2017 | 15.45% |
| Dec 31, 2016 | 28.48% |
| Sep 30, 2016 | 2.02% |
| Jun 30, 2016 | 9.65% |
| Mar 31, 2016 | -5.59% |
| Dec 31, 2015 | 5.22% |
| Sep 30, 2015 | 11.52% |
| Jun 30, 2015 | 3.87% |
| Mar 31, 2015 | 7.02% |
| Dec 31, 2014 | 14.70% |
| Sep 30, 2014 | 26.62% |
| Jun 30, 2014 | 4.50% |
| Mar 31, 2014 | -8.41% |
| Dec 31, 2013 | 15.52% |
| Sep 30, 2013 | 4.80% |
| Jun 30, 2013 | -12.84% |
| Mar 31, 2013 | -18.79% |
| Dec 31, 2012 | -10.52% |
| Sep 30, 2012 | -12.89% |
| Jun 30, 2012 | -11.25% |
| Mar 31, 2012 | -34.75% |
| Dec 31, 2011 | -81.27% |
| Sep 30, 2011 | -43.96% |
| Jun 30, 2011 | -112.01% |
| Mar 31, 2011 | -182.25% |